Join to View Full Profile
200 Hawthorne LnFl 3Charlotte, NC 28204
Phone+1 704-384-9234
Fax+1 704-417-4400
Dr. Limentani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Steven Limentani is a seasoned Oncologist based in Charlotte, NC, specializing in breast cancer and hematologic oncology. His educational background includes a residency in Internal Medicine at Beth Israel Deaconess Medical Center, followed by a Hematology and Medical Oncology Fellowship at Tufts Medical Center. He holds numerous prestigious positions such as Senior Vice President, Clinical Integration at Atrium Health and previous ones at Novant Health and Mission Hospital. He has managed conditions like amyloidosis, hematologic oncology, breast cancer, myelodysplasia, and myelofibrosis. Dr. Limentani also contributed extensively to the field through his publications and participation in clinical trials relating to breast cancer treatment. His work has been well-recognized, earning him awards like America's Top Doctors and Top MD from Consumers Checkbook.
Dr. Limentani moved increasingly to administrative roles and currently works to integrate clinical services across the Advocate Health System to facilitate and improve the care of patients.
Education & Training
- Tufts Medical CenterFellowship, Hematology and Medical Oncology, 1989 - 1992
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1986 - 1989
- Tufts University School of MedicineClass of 1986
Certifications & Licensure
- NC State Medical License 1995 - 2026
- MA State Medical License 1988 - 2022
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- America's Top Doctors for Cancer Castle Connolly, 2007-2013
- Charlotte Magazine Castle Connolly, 2005
- Join now to see all
Clinical Trials
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Dec 10
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Feb 08
Publications & Presentations
PubMed
- 23 citationsAdjuvant trastuzumab emtansine in HER2-positive breast cancer patients with HER2-negative residual invasive disease in KATHERINE.Sibylle Loibl, Chiun-Sheng Huang, Max S Mano, Eleftherios P Mamounas, Charles E Geyer Jr
NPJ Breast Cancer. 2022-09-19 - 1 citationsRe: Using the 21‐gene assay from core needle biopsies to choose neoadjuvant therapy for breast cancer: A multicenter trial. Journal of Surgical Oncology 2017;115(8):91...Harry D. Bear, Wen Wan, André Robidoux, Peter Rubin, Steven Limentani
Journal of Surgical Oncology. 2017-07-28 - 72 citationsUsing the 21-gene assay from core needle biopsies to choose neoadjuvant therapy for breast cancer: A multicenter trial.Harry D. Bear, Wen Wan, André Robidoux, Peter Rubin, Steven Limentani
Journal of Surgical Oncology. 2017-06-01
Press Mentions
- Novant Health Rebrands Cancer Care to Show a Comprehensive Approach in a Growing SectorSeptember 2nd, 2020
- Novant Health Announces New Leader in Cancer ServicesJanuary 18th, 2017
Grant Support
- GLA Domain In Blood Clotting ProteinsNational Heart, Lung, And Blood Institute1990–1994
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: